Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843788 · ClinicalTrials.gov registry record · NA
TENS and Opioid Use After Cesarean Delivery
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03843788 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 16 participants.
The verdict
NCT03843788, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
We propose to explore the effects of Transcutaneous Electrical Nerve Stimulation (TENS) therapy in the pain management of postpartum women. A. Objectives * To determine if the addition of TENS therapy to the pain management of women post-cesarean section leads to less opioid medication use. * To evaluate the efficacy of TENS therapy as a means of alternative pain relief for women post-cesarean section with a history of opioid use. B. Hypotheses / Research Question(s) We hypothesize that patients that receive TENS therapy will report lower pain scores and request less opioid medication than the control group. We anticipate improved control in particular in the group of women with a history of opioid use. Additionally, we believe that the TENS therapy will show benefits in other postpartum outcomes including time to bowel movement, level of sedation, and time to out of bed. Overall, we anticipate that this pilot study will support the application of TENS therapy in postpartum pain management.
Interventions
- DEVICE Transcutaneous Electrical Nerve Stimulation (TENS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-11-09 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03843788
The ClinicalTrials.gov registry entry for NCT03843788 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Electrical Nerve Stimulation (TENS) is the first listed.
NCT03843788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03843788 about?
NCT03843788 is a clinical study titled "TENS and Opioid Use After Cesarean Delivery". We propose to explore the effects of Transcutaneous Electrical Nerve Stimulation (TENS) therapy in the pain management of postpartum women. A. Objectives * To determine if the addition of TENS therapy to the pain management of women post-cesarean section leads to less opioid medication use. * To e...
What is the current status of trial NCT03843788?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2018-11-09. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT03843788?
The interventions under investigation include: Transcutaneous Electrical Nerve Stimulation (TENS) (DEVICE).
Who is sponsoring clinical trial NCT03843788?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.